Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Urs F Greber

Showing results (121-130 of 133) with videos related to

Pageof 14
Sort By:
Molecular Therapy. Methods & Clinical Development|March 5, 2021
iMATCH: an integrated modular assembly system for therapeutic combination high-capacity adenovirus gene therapyDominik Brücher, Nicole Kirchhammer, Sheena N Smith, et al.
Nature Communications|February 2, 2018
Adenoviral vector with shield and adapter increases tumor specificity and escapes liver and immune controlMarkus Schmid, Patrick Ernst, Annemarie Honegger, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 2020
Dynamic competition for hexon binding between core protein VII and lytic protein VI promotes adenovirus maturation and entryMercedes Hernando-Pérez, Natalia Martín-González, Marta Pérez-Illana, et al.
Journal of Virology|May 19, 2017
Cell Cycle-Dependent Expression of Adeno-Associated Virus 2 (AAV2) Rep in Coinfections with Herpes Simplex Virus 1 (HSV-1) Gives Rise to a Mosaic of Cells Replicating either AAV2 or HSV-1Francesca D Franzoso, Michael Seyffert, Rebecca Vogel, et al.
Plos Pathogens|March 10, 2018
Lung macrophage scavenger receptor SR-A6 (MARCO) is an adenovirus type-specific virus entry receptorNicole Stichling, Maarit Suomalainen, Justin W Flatt, et al.
Current Research in Virological Science|January 24, 2022
Identification of broad anti-coronavirus chemical agents for repurposing against SARS-CoV-2 and variants of concernLuca Murer, Romain Volle, Vardan Andriasyan, et al.
Viruses|July 27, 2022
Sequence-Specific Features of Short Double-Strand, Blunt-End RNAs Have RIG-I- and Type 1 Interferon-Dependent or -Independent Anti-Viral EffectsAbhilash Kannan, Maarit Suomalainen, Romain Volle, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2024
Metagenomic study of lake microbial mats reveals protease-inhibiting antiviral peptides from a core microbiome memberChandrashekhar Padhi, Christopher M Field, Clarissa C Forneris, et al.
Mbio|September 28, 2017
Erratum for Maler et al., "Key Role of the Scavenger Receptor MARCO in Mediating Adenovirus Infection and Subsequent Innate Responses of Macrophages"Mareike D Maler, Peter J Nielsen, Nicole Stichling, et al.
Mbio|August 3, 2017
Key Role of the Scavenger Receptor MARCO in Mediating Adenovirus Infection and Subsequent Innate Responses of MacrophagesMareike D Maler, Peter J Nielsen, Nicole Stichling, et al.
Pageof 14

Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
Molecular Therapy. Methods & Clinical Development|March 5, 2021
iMATCH: an integrated modular assembly system for therapeutic combination high-capacity adenovirus gene therapyDominik Brücher, Nicole Kirchhammer, Sheena N Smith, et al.
Nature Communications|February 2, 2018
Adenoviral vector with shield and adapter increases tumor specificity and escapes liver and immune controlMarkus Schmid, Patrick Ernst, Annemarie Honegger, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 2020
Dynamic competition for hexon binding between core protein VII and lytic protein VI promotes adenovirus maturation and entryMercedes Hernando-Pérez, Natalia Martín-González, Marta Pérez-Illana, et al.
Journal of Virology|May 19, 2017
Cell Cycle-Dependent Expression of Adeno-Associated Virus 2 (AAV2) Rep in Coinfections with Herpes Simplex Virus 1 (HSV-1) Gives Rise to a Mosaic of Cells Replicating either AAV2 or HSV-1Francesca D Franzoso, Michael Seyffert, Rebecca Vogel, et al.
Plos Pathogens|March 10, 2018
Lung macrophage scavenger receptor SR-A6 (MARCO) is an adenovirus type-specific virus entry receptorNicole Stichling, Maarit Suomalainen, Justin W Flatt, et al.
Current Research in Virological Science|January 24, 2022
Identification of broad anti-coronavirus chemical agents for repurposing against SARS-CoV-2 and variants of concernLuca Murer, Romain Volle, Vardan Andriasyan, et al.
Viruses|July 27, 2022
Sequence-Specific Features of Short Double-Strand, Blunt-End RNAs Have RIG-I- and Type 1 Interferon-Dependent or -Independent Anti-Viral EffectsAbhilash Kannan, Maarit Suomalainen, Romain Volle, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2024
Metagenomic study of lake microbial mats reveals protease-inhibiting antiviral peptides from a core microbiome memberChandrashekhar Padhi, Christopher M Field, Clarissa C Forneris, et al.
Mbio|September 28, 2017
Erratum for Maler et al., "Key Role of the Scavenger Receptor MARCO in Mediating Adenovirus Infection and Subsequent Innate Responses of Macrophages"Mareike D Maler, Peter J Nielsen, Nicole Stichling, et al.
Mbio|August 3, 2017
Key Role of the Scavenger Receptor MARCO in Mediating Adenovirus Infection and Subsequent Innate Responses of MacrophagesMareike D Maler, Peter J Nielsen, Nicole Stichling, et al.
Pageof 14